Sign Out
Use in Pregnancy & Lactation: This drug should be administered to pregnant or possibly pregnant women only if the anticipated therapeutic benefit is thought to outweigh any potential risk. (The safety of this drug in pregnant women has not been established.)
Nursing should be interrupted when this drug is administered to. (Rat studies have shown that rebamipide is excreted in the breast milk.)
Use in Children: The safety of this drug in low-birth-weight infants, newborns, suckling infants, infants and children has not been established. (Clinical experience is insufficient.)
Use in the Elderly: Special care is required in elderly patients to minimize the risk of gastrointestinal disorders, because these patients may be physiologically more sensitive to this drug than younger patients.
